 |
6 Diseases |  |
0 Trials |
|
0 Trials |  |
5 News |  |
- |||| ISIS-PTP1BRx / Ionis
Trial completion, Enrollment change, Trial primary completion date: Safety, Tolerability, and Efficacy of ISIS-PTP1BRx in Type 2 Diabetes (clinicaltrials.gov) - Mar 3, 2015
P2, N=92, Completed, Sponsor: Isis Pharmaceuticals
Active, not recruiting --> Completed | N=75 --> 92 | Trial primary completion date: Jan 2015 --> Oct 2014
- || ISIS-PTP1BRx / Ionis
Trial primary completion date: Safety, Tolerability, and Efficacy of ISIS-PTP1BRx in Type 2 Diabetes (clinicaltrials.gov) - Nov 25, 2014
P2, N=75, Active, not recruiting, Sponsor: Isis Pharmaceuticals
Active, not recruiting --> Completed | N=75 --> 92 | Trial primary completion date: Jan 2015 --> Oct 2014 Trial primary completion date: Sep 2015 --> Jan 2015
- ||| ISIS-PTP1BRx / Ionis
Enrollment closed: Safety, Tolerability, and Efficacy of ISIS-PTP1BRx in Type 2 Diabetes (clinicaltrials.gov) - Sep 5, 2014
P2, N=75, Active, not recruiting, Sponsor: Isis Pharmaceuticals
Trial primary completion date: Sep 2015 --> Jan 2015 Recruiting --> Active, not recruiting
- ||||| ISIS-PTP1BRx / Ionis
New P2 trial: Safety, Tolerability, and Efficacy of ISIS-PTP1BRx in Type 2 Diabetes (clinicaltrials.gov) - Aug 6, 2013
P2, N=75, Recruiting, Sponsor: Isis Pharmaceuticals
- |||| ISIS-PTP1BRx / Ionis
Enrollment open: Safety, Tolerability, and Efficacy of ISIS-PTP1BRx in Type 2 Diabetes (clinicaltrials.gov) - Aug 6, 2013
P2, N=75, Recruiting, Sponsor: Isis Pharmaceuticals
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting